Abstract
Introduction:
The scaffold is a place for regeneration of new bone and bone tissue growths in tissue engineering applications. hADMSC is a multipotent cell which can differentiate into osteogenic, chondrogenic and adipogenic. Y-TZP has been shown to have several advantages over other ceramics because of its hard nature, namely fracture toughness and high flexural strength.
Aim:
This study aimed to analyze the biocompatibility of Y-TZP as a scaffold seeded with hADMSCs by in vitro analysis.
Material and methods:
This research involved several processes, namely Y-TZPS manufacture process, XRD examination, differentiation and characterization of hADMSC, SEM observation, and then TT.
Results:
The results of the XRD examination showed that Y-TZPSs had sharp peaks. It suggests that they had high crystal purity. The marked expression of the characterization of hADMSC is the positive expression of Cluster of differentiation (CD), namely CD 90, CD 73 and CD 105 above NMT and negative expressions of CD 14, CD 19, CD 34, CD 45 and also HLA-DR below NLT. The analysis of observations on the Y-TZPSs with SEM, subsequently, indicated the porosity of Y-TZPSs, as a result, the adhesion of HADMSCs occurred and grew in the porosity in the Y-TZPSs.
Conclusions:
Y-TZPSs with low porosity and toxicity can be able to proliferate and differentiate if seeded with hADMSC. Y-TZPSs are expected to be used as implantable biomaterials using hADMSCs with high biocompatibility.
Keywords: Electron Scanning Microscopy, Mesenchymal Stem Cell, Toxicity, X-ray Diffractions, Y-TZP ceramic
1. INTRODUCTION
Tissue engineering has components consisting of cells, scaffolds, growth factors called triad of network engineering. The scaffold is a material made from polymeric material that can add material support to the material in the attachment of the cell and the development of subcutaneous tissue. The scaffold is also known as an important component in tissue engineering (1). The scaffold is a place to regenerate cell growth and new bone tissue in tissue engineering applications (2).
On the other hand, titanium implants often trigger periimplanitis and mucositis periimplanitis elevating from 28% to 56% among 80% of subjects taken (3). Hence, implants made of Zirconia can be suggested to patients who have an allergic reaction to titanium or other metals. In the biological environment, test and osseointegration power, there is still little research done on Zirconia on experimental animals (4).
Tetragonal Zirconia Polycrystal (Y-TZP), consequently, can be considered as an alternative dental implant material that can replace implant material that has been used, namely Titanium (5). Y-TZP is also known to be more esthetically and bio compatibly than titanium, thus, Y-TZP as an alternative dental implant material can function properly as a scaffold (6, 7). Besides, excess Y-TZP is rigid and not easily broken compared to other ceramic materials. In the field of dentistry, ceramic materials have high biocompatibility, namely thermal conductivity, low corrosion rates and high aesthetics in mucogingival in implant preparation (8).
In addition, Mesenchymal stem cells (MSC) can play an active role in repairing and maintaining tissue homeostasis. Osteoblasts can have potential for bone regeneration where the ability of cells that differentiate as effector cells (3, 9, 10-16). Human Adipose Derived Mesenchymal Stem Cells (hADMSC) is a multipotent cell which can differentiate into osteogenic, chondrogenic, and adipogenic. hADMSC has many similar characteristics of Bone Marrow stem cells (BMSCs) but hADMSC has a high proliferation rate compared to BMSCs (10).
2. AIM
This research aimed to calcify the biocompatibility of Y-TZP as a scaffold (Y-TZPS) seeded with hADMSCs by performing X-Ray Diffraction (XRD) examination, scanning electron microscope (SEM) observation test, and in vitro toxicity test (TT).
3. MATERIAL AND METHODS
Y-TZPS Manufacturing Process
In this research, scaffolds used were made in a dental laboratory. Scaffold samples used were taken from Y-TZP [Vita YZ Interne Untersuchungen, VITA F & E: VITA Zahnfabrik H. Rauter GmbH & Co. KG Ressort Forschung und Entwicklung Spitalgasse 379713 Bad Säckingen Dipl.-Ing] [11]. Y-TZP have grooves and holes in their rod section with a Y-TZP size (Ø = 2.9mm, P = 3mm). In the manufacturing of Y-TZPS, sterilization was carried out using gamma cell radiation at Irradiation, Electromechanics, and PAIR-BATAN Instrumentation Center in Jakarta.
XRD Examination
Samples of Y-TZP were made in the forms of fine crystalline powder with a minimum size of 5 mg. To conduct XRD examination, [XRD D8 Focus, The Bruker Corporation (NASDAQ: BRKR), Billerica, Massachusetts, USA] and HCB were taken from male resection maxilla patients who were trafficking victims. Crystal powder that had been pressed into sample container, had a smooth surface, and was resistant to the samples at a 45-degree angle. A small amount of solid sample by depositing the substrate on a thin film placed on a sliding glass from the microscope, then the intensity of the beam is reduced from 40 KV and 40mA to 30kV and 30mA.
Log XRD analysis
The log must be filled in to operate the XRD before starting the test to be recorded. The XRD operation aims to check the alarm lights on the right side of the. Next, the XRD spreadsheet log on the desktop was filled in. KV setting, then was conducted by increasing the addition of 10kV at 30 seconds to 40kV. Subsequently, <set> button was pressed after every change. An mA setting of 5-10 then was carried out with an addition of 10mA to 40mA. Afterwards, a permanent parameter file was created for automatic scanning stored in the XRD wizard.
Adipose Sampling Procedure
Adipose or body fat tissue samples taken from participants with elective indications and no medical complications at Universitas Airlangga Hospital, Surabaya in accordance with certain criteria, such as pregnant women who underwent the birth process by cesarean section or Cesarean section due to abnormal fetus location
Adipose sampling was performed with an oval slice on the upper surface, remaining adipose on the inner surface together with muscles and other tissues, with an area of approximately 5 cm3. Adiposa then was put into a transport medium and taken to the Research and Development of Stem Cell Universitas Airlangga Laboratory (RDSCUAL), Surabaya for hADMSC isolation, cultural expansion, and TT.
Those Adiposa were washed with PBS solution, those adipose was cut and chopped until smooth and then were added by collagenase enzyme. Afterwards, they were soaked and incubated at 37° C for 45 minutes. It was added to the pellets, and planted on a 10 cm plate until the cells were attached to the base of each petri and labeled with the patient’s identity in the form of the name and processing date, and then incubated in CO2 incubator.
Isolation and Culture Expansion Procedure of hADMSC
Isolation of hADMSC was using lipoaspirate enzymatic to separate SVF. Cells, on the other hand, are known consisting of stroma, progenitor SCs, WBCs, ECs, periocytes, and RBCs. Isolation and Culture Expansion Procedure of hADMSC according to (Banyard et al., 2015) without modification until passage 4 (12).
Characterization and Differentiation of hADMSC Phenotype
Characterization and differentiation of the MSC phenotype in hADMSC culture were conducted in two types of immunostaining methods, namely immunocytochemical staining and flowcytometry test (FT). Identification of hADMSCs was carried out at the SCIL of PT. Kalbe Farma Tbk with MSC phenotype kit after the fourth passage. Cells that have adipogenic, osteogenic, or chondrogenic properties are oil red-O staining (OROS) for adipogenic and Alizharin staining for osteogenic by dripping lipids and then fixed with 4% formalin (13). Differentiation of hADMSC to determine adipogenic and osteogenic according to (Jeon et al. 2016) without modification (20).
Flowcytometry
Flowcytometry was performed to make monolayer cells change into single cells through trypsination process. After that, Flowcytometry is carried out according to the procedure from (Van Pham et al, 2016) without modification (14, 20, 21).
hADMSC Seeding Procedure on Y-TZPS
In Y-TZPS, hADMSCs were hatched by immersing them in DMEM / F12 medium for 1 day. The old medium, then was removed and replaced by the new one. After one day, the Y-TZPSs were put into 24 culture wells (M24) with 2 x 106 cells (200 μL/well). Those wells, then were incubated for 1 hour at 370 C with 5% CO2. In the well the medium was added as much as 1.3 mL / well and incubated with 5% CO2 at 370 C. Periodically, the tubes were rocked to mix cells with the suspensions and Y-TZPSs. The cell-coated Y-TZPSs then were ready in the next 3 days for SEM.
Observation of Y-TZPS Seeded with hADMSCs
Cells that had been cultured into the Y-TZPSs were fixed with 2% glutaraldehyde solution for 2 hours at 400 C, then washed with PBS solution 3 times for 5 minutes, replaced with 1% OAS for 1 hour at 400 C, and washed with PBS again. After that, they were dehydrated with alcohols from low to absolute levels for 15 minutes each, then replaced with absolute AAL as a preservative until dry time. Next, Y-TZPS were dried with CPD. They then were affixed to the stub by using special glue and coated with pure gold with a vacuum evaporator fixation tool. The Y-TZPSs then were ready to be observed and photographed with SEM at the DME, FIE, ITS, Surabaya.
TT on Y-TZPS and HCB
TT on Y-TZPS and HCB against hADMSC cell culture, trypination of a petri plate containing 2.5 x 106 cells was carried out. Next, resuspension was conducted in DMEM / F12 medium and centrifuged. Afterwards, the Pellets are planted into M96 of 5 x 104 cells / well, then incubated with 5% CO2 at 370 C for 24 hours. When 80% of the growth was obtained, the Y-TZPS were added to ½ parts of the wells. Subsequently, 100 µL of DMEM / F12 medium was added, and incubated with 5% CO2 at 370 C for 20 hours. After that, the wells were put in MTT as much as 5 mg / mL (25μL / well), then incubated for 4 hours, and observed under an inverted microscope. The Y-TZP and medium, then were discarded, and sDMSO was added into each well as many as 200 μL. Color changes in those wells were then read by the MTT Assay with Elisa Reader at a wavelength of 595 nm.
Ethics
This study has been evaluated and approved by RSUA (Airlangga University Hospital) Ethics Committee, Surabaya Indonesia with Ethical Clearance Number: 107/KEH/2018.
4. RESULTS
The manufacturing of Y-TZPSs and mineral analysis
In the manufacturing of Y-TZPSs, there was ad distortion so that they did not only experience shrinkage in both dimension and density of their material, but their color also changed into browner than their original white color. These changes, as a result, had an impact on both the material density and the Y-TZPS density (Figure 1A). To know porosity in the scaffolds, magnification in using an SEM was required.
Figure 1. Distortion of Y-TZPSs. A)Y-TZP had grooves and holes in the rod section with size (Ø = 2.9mm, P = 3mm). B) mineral analysis with XRD examination. The peak on the graph of material analysis with XRD examination of Y-TZP minerals, HCB minerals, and Y-TZP minerals combined with HCB minerals.

The results of the mineral analysis with XRD examination were illustrated by a graph of Y-TZP, HCB, and a combination of both (Figure 1B). In Y-TZP, there was a high and sharp peak on the graph of material analysis with XRD examination. The Y-TZP graph was also known to have a low frequency. Similarly, in HCB there was a sharp peak with low frequency. Thus, to see their differences, XRD examination was performed on Y-TZP minerals combined with HCB minerals. The results showed that the height of the peak in Y-TZP was higher than that in HCB. Coefficient of thermal expansion had been determined by XRD measurement (15).
Characterization and differentiation of hADMSC phenotype
Isolation and Culture Expansion on hAMDSC of passage 1 was observed on the 3rd day followed by passages 2, 3, and 4 respectively until day 12. In passage 4, the cell density increased and was ready for both the adipogenic and osteogenic differentiations (AD and OD) of hADMSCs and the characterization of hADMSCs (Figure 2).
Figure 2. Isolation, differentiation, characterization and Graph Characterization Analysis (CA) of hADMSC. Adipogenic differentiation analysis (ADA) of hADMSCs with oil red-O staining (OROS). Osteogenic differentiation analysis (ODA) of hADMSCs with Alizahrin Staining. CA by immunocytochemical staining and flowcytometry test (FT).

Based on results of the ADA of hADMSC with OROS, there were more vacuoles than in cell controls. This shows that hADMSCs have properties that can be used for AD.
Whereas the osteogenic differentiation analysis of hADMSCs with alizharin staining, it is indicated that hADMSCs have properties that can be differentiated towards OD by brownish vacuoles.
Based on the CA of hADMSC, MSCs on the expressions of CD 90 (97.61%), CD 73 (99.56%) and CD 105 (97.41%) were above 95%, while they on CD 14 (0.74%), CD 19 (0.83%), CD 34 (1.45%), CD 45 (1.42%) and also HLA-DR (0.84%) were below 2%.
Table 1. Characterization Analysis (CA) of hADMSCs. Cell count: 647,500 Cells, Remark: FIO: For Information Only, NLT: Not Lower Than, NMT, Not More Than.
| Result | ||
|---|---|---|
| Test Method | Specification | ADSC-HMN-P4-220518 |
| Viability | FIO | 94.87% |
| Biomarker CD 1052 | NLT 95 % | 97.41 % |
| Biomarker CD 732 | NLT 95 % | 99.56 % |
| Biomarker CD 902 | NLT 95 % | 97.61 % |
| Biomarker CD 452 | NMT 2 % | 1.42 % |
| Biomarker CD 342 | NMT 2 % | 1.45 % |
| Biomarker CD 142 | NMT 2 % | 0.74 % |
| Biomarker CD 192 | NMT 2 % | 0.83 % |
| Biomarker HLA-DR | NMT 2 % | 0.84 % |
Observation Analysis (OA) on Y-TZPS with SEM
Results of OA on Y-TZPS using SEM with magnifications of 50x, 2500x, 5000x, and 7000x showed porosity in Y-TZPS. Meanwhile, results of the OA on Y-TZPS seeded with hADMSCs using SEM showed that there were cells attached to the surface of Y-TZPS seeded and fixed (Figure 4).
Figure 4. Toxicity Test TT of Y-TZPSs and HCB (Before and After MTT Assay). CC = Control, HCB = Human Cortical Bone, Y-TZPS=Tetragonal Zirconia Polycrystal.
Toxicity Test
Results of the TT on Y-TZPSs and HCB in 96M revealed that both Y-TZPSs and HCB were not toxic to hADMSC.
Table 2 showed that Y-TZPSs seeded with hADMSCs had a higher percentage of LCs is 97% compared to HCB with hADMSCs (89%). In Figure 4, the results of the TT on HCB, Y-TZPSs, and CCs indicated that cells could live on HCB and Y-TZPSs both before and after MTT Assay.
Table 2. Results of the MTT Assay on Scaffolds.
| No | Medium Control (MC) | CC | HCB | Y-TZPS |
|---|---|---|---|---|
| 1 | 0,095 | 0,942 | 0,843 | 0,910 |
| 2 | 0,092 | 0,945 | 0,849 | 0,923 |
| 3 | 0,091 | 0,943 | 0,852 | 0,921 |
| 4 | 0,092 | 0,949 | 0,846 | 0,920 |
| 5 | 0,092 | 0,943 | 0,850 | 0,918 |
| Total | 0,462 | 4,722 | 4,240 | 4,592 |
| Mean | 0,092 | 0,944 | 0,848 | 0,918 |
| (%) Living Cells (LC) | 89 | 97 | ||
Figure 3. Observation Analysis on Y-TZPS by Scanning Electron Microscope (SEM). Y-TZPS 50x, 2500x, 5000x, and 7000x, (f) Y-TZPS seeded with hADMSCs 50x, 350x, 2500x, 5000x and 7000x.

5. DISCUSSION
The results of the XRD examination showed that Y-TZPSs had a sharper peak than human bone. This indicates that minerals contained in the Y-TZPSs have higher crystalline purity than HCB. More ever, the characterization and differentiation of adipose phenotypes taken from selected human donors show that MSC of the adipose referred to as hADMSC. Expressions emerged in the differentiation of hADMSCs then were used for AD and OD. The expressions marked in the characterizations that are not only positive are from CD 90, CD 73 and CD 105 above 95%, while they are on CD 14, CD 19, CD 34, CD 45 and also HLA-DR below 2% which means that cells as MSC.
Observation of Y-TZPs with SEM, furthermore, found that there were many large porouses due to the porosity of Y-TZPSs after the 7000x enlargement, which HADMSCs could be able to adhere to and grow in. Besides, the results TT of the Y-TZPs indicated that there was a similar low toxicity between the Y-TZPS and the HCB. hADMSCs that had been seeded could also live and would not be toxic to the Y-TZPS. Even, they had more LCs than HCB as depicted in Table 2 and Figure 4. As a result, biomaterials are developed to interact with the tissue, so they can induce repairing of the tissue (16).
Y-TZPSs, has a great aesthetical performance, biocompatibility, and mechanical properties (5). HCB has been reported to be effective to induce regeneration in periodontal intra-coniac deficiency (17). However, the HCB is isotropic and not homogeneous. The osseointegration rate is 100%, also shown to be incompatible with a non-linear frictional contact analysis and good osseointegration between implants and HCB (18). Based on the data above, Y-TZPSs have high porosity, but hADMSCs are still able to adhere and grow, as well as not lead to toxicity. The hypothesis with Y-TZPSs-hADMSCs in tissue engineering so that it has large osseointegration capabilities if Y-TZPSs are without hADMSCs. High power and osseointegration acceleration can reduce implantation failure. In the future, Y-TZPSs-hADMSCs made a tissue engineering in dental implantation and orthopedics.
6. CONCLUSION
This study conclude that Y-TZPSs- hADMSCs as an biomaterial had high biocompatibility for osseointgrated acceleration of implantation.
Acknowledgments:
This research has been discussed and supported by the Stem Cell and Cancer Institute. We would like thanks to Rista NR for manuscript discussion and team of Biosains Institute, Brawijaya University for providing the laboratory facilities.
Authors’ contributions:
All the authors were involved during primary data collection, analysis, documentation of the collection and writing the publication. Substantial contribution to conception and design: AR, Substantial contribution to acquisition of data: AR, IB, IL, Substantial contribution to analysis and interpretation of data : AR, LM, FA, LH, Drafting the article : AR, LH, Critically revising the article for important intellectual content : AR, FA, FF, LH and Final approval of the version to be published : AR, FF.
Financial support and sponsorship:
None.
Conflict of interest:
There are no conflict of interest.
REFERENCES
- 1.Chan BP, Leong AKW. Scaffolding in tissue engineering: general approaches and tissue-specific considerations. 2008 doi: 10.1007/s00586-008-0745-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ecmjournal W. Towards in vitro vascularisation of collagen-GAG scaffolds. 2011;21(1):2011–2015. doi: 10.22203/ecm.v021a02. [DOI] [PubMed] [Google Scholar]
- 3.Lindhe J, Meyle J. Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol. 2008;35(Suppl. 8):282–285. doi: 10.1111/j.1600-051X.2008.01283.x. [DOI] [PubMed] [Google Scholar]
- 4.Kohal RJ, Schwindling FS, Bächle M, Spies BC. Peri-implant bone response to retrieved human Zirconia oral implants after a 4-year loading period: A histologic and histomorphometric evaluation of 22 cases. J Biomed Mater Res Part B Appl Biomater. 2015:1–10. doi: 10.1002/jbm.b.33512. [DOI] [PubMed] [Google Scholar]
- 5.Hirano T, Sasaki H, Honma S, Furuya Y, Miura T, Yajima Y. Proliferation and osteogenic differentiation of human mesenchymal stem cells on zirconia and titanium with different surface topography. Dent Mater J. 2015;34(6):872–880. doi: 10.4012/dmj.2015-129. [DOI] [PubMed] [Google Scholar]
- 6.Gruber R, Bosshardt DD. Stem Cell Biology and Tissue Engineering in Dental Sciences. Elsevier Inc.; 2014. Dental Implantology and Implants–Tissue Interface; pp. 735–747. [Google Scholar]
- 7.Winkelhoff A, Cune M. Zirconia Dental Implants: A Clinical, Radiographic, and Microbiologic Evaluation up to 3 Years. Int J Oral Maxillofac Implants. 2014;29(4):914–920. doi: 10.11607/jomi.3293. [DOI] [PubMed] [Google Scholar]
- 8.Degidi M, Artese L, Franceschini N, Sulpizio S, Piattelli A, Piccirilli M. Matrix metalloproteinases 2, 3, 8, 9, and 13 in the peri-implant soft tissues around titanium and zirconium oxide healing caps. Int J Oral Maxillofac Implants. 2013;28(6):1546–1551. doi: 10.11607/jomi.2502. [DOI] [PubMed] [Google Scholar]
- 9.Coates DE. In vivo bone regeneration on titanium devices using serum-free grown adipose-derived stem cells , in a sheep femur model. 2016:1–12. doi: 10.1111/clr.12761. [DOI] [PubMed] [Google Scholar]
- 10.Shi Y, Niedzinski JR, Samaniego A, Bogdansky S, Atkinson BL. Adipose-Derived Stem Cells Combined with a Demineralized Cancellous Bone Substrate for Bone Regeneration. Tissue Eng Part A. 2012;18(13–14):1313–1321. doi: 10.1089/ten.TEA.2011.0357. [DOI] [PubMed] [Google Scholar]
- 11.VITA YZ. VITA shade, VITA made. Technical and scientific documentation [Google Scholar]
- 12.Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33(11):1402–1416. doi: 10.1016/j.exphem.2005.07.003. [DOI] [PubMed] [Google Scholar]
- 13.Banyard DA, Salibian AA, Widgerow AD, Evans GRD. Implications for human adipose-derived stem cells in plastic surgery. J Cell Mol Med. 2015;19(1):21–30. doi: 10.1111/jcmm.12425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Biosciences BD, Laser V, Laser B, Laser G, Laser Y, Laser R. Multiparameter Flow Cytometric Analysis of Human Mesenchymal Stem Cells Multiparameter Flow Cytometric Analysis of Human Mesenchymal Stem Cells. 2010 Oct;:1–2. [Google Scholar]
- 15.Mohanraj J, Capria E, Benevoli L, Perucchi A, Demitri N, Fraleoni-Morgera A. XRD- and infrared-probed anisotropic thermal expansion properties of an organic semiconducting single crystal. Phys Chem Chem Phys. 2018 doi: 10.1039/c7cp05209j. [DOI] [PubMed] [Google Scholar]
- 16.Vishwakarma A, Sharpe P, Shi S, Ramalingam M. Stem Cell Biology and Tissue Engineering in Dental Sciences. Elsevier Inc.; 2015. Chapter 1 An Introduction to Stem Cell Biology and Tissue Engineering; pp. 1–13. [Google Scholar]
- 17.Shin SY, Rios HF, Giannobile WV, Oh TJ. Stem Cell Biology and Tissue Engineering in Dental Sciences. Elsevier Inc; 2015. Periodontal Regeneration; pp. 459–469. [Google Scholar]
- 18.Bacchi AR. Stress distribution in fixed-partial prosthesis and peri-implant bone tissue with different framework materials and vertical misfit levels: a three-dimensional finite element analysis. J Oral Sci. 2013;55(3):239–244. doi: 10.2334/josnusd.55.239. [DOI] [PubMed] [Google Scholar]
- 19.Caplan AI. Adult mesenchymal stem cells: When, where, and how. Stem Cells Int. 2015 doi: 10.1155/2015/628767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jeon YJ, Kim J, Cho JH, Chung HM, Chae JI. Comparative Analysis of Human Mesenchymal Stem Cells Derived From Bone Marrow, Placenta, and Adipose Tissue as Sources of Cell Therapy. Cell Biochem. 2016;117(5):1112–1125. doi: 10.1002/jcb.25395. [DOI] [PubMed] [Google Scholar]
- 21.Van Pham P, Truong NC, Le PT-B, Tran TD-X, Vu NB, Bui KHT. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications. Cell Tissue Bank. 2016;17(2):289–302. doi: 10.1007/s10561-015-9541-6. [DOI] [PubMed] [Google Scholar]

